Skip to main content
. Author manuscript; available in PMC: 2024 May 20.
Published in final edited form as: Heart Rhythm. 2022 Dec 8;20(3):440–447. doi: 10.1016/j.hrthm.2022.12.003

Table 1.

Base case clinical and costing inputs

Variable Input Range Distribution Reference
Clinical Inputs
All-cause death at 1 year n/a Weibull TRUST3
IPE Strategy
 Hospitalization / ED Visits, per patient year 0.13 0.10 – 0.16 Beta TRUST3
 Clinic Visits, per patient year 4.00 3.00 – 5.00 Beta TRUST3
RPM-Conventional Strategy
 Hospitalization / ED Visits, per patient year 0.11 0.08 – 0.14 Beta TRUST3
 Clinic Visits, per patient year 2.50 1.88 – 3.13 Beta TRUST4
 Median Number of Alerts per patient 1.00 0 – 3.00 Triangle TRUST4
RPM-Alert Strategy
 Hospitalization / ED Visits, per patient year 0.11 0.08 – 0.14 Beta TRUST3
 Clinic Visits, per patient year 0.80 0.40 – 1.20 Beta TRUST4
 Median Number of Alerts per patient 1.00 0 – 3.00 Triangle TRUST4
Proportion of Hospitalization (versus ED) 0.82 Beta 10
Lead / Generator Revision, per patient year 0.02 0.01 – 0.06 Beta TRUST4
Utilities
Alive with ICD 0.85 SD ± 0.3 Beta 33
Disutility HF Hospitalization −0.0066 −0.0135 to 0 Beta 34
Costs (2021 USD)
Remote Monitoring Equipment* 2,000 ±50% Gamma Assumption
Cost per Hospitalization 17,389 13,042 – 21,736 Gamma 15
Cost per ED Visit 1,726 1,413 – 2,038 Gamma 14
Annual Outpatient Costs of HF 3,964 3,057 – 5,091 Gamma 35
Clinic Cost, per visit 164 ±50% Gamma 13
Remote monitoring cost, per assessment 64 ±50% Gamma 13
Lead / Generator Revision Cost 35,534 23,955 – 51,038 Gamma 20, 36
Annual discount rate 0.03 n/a n/a 19
*

Cost of remote monitoring equipment added for sensitivity analysis.

Abbreviations: ED – emergency department; HF – heart failure; ICD – implantable cardioverter defibrillator; IPE – in-person evaluation; RPM – remote patient management.